EQUITY PLANS AND SHARE REPURCHASE PROGRAM
Stock-Based Compensation Plans

We have one primary stock incentive plan, the 2009 EIP, under which we have granted RSUs, stock options and PSUs.

Our board of directors approved the 2009 EIP in 2009 and amended the plan in 2019. The maximum aggregate number of shares that may be issued under the 2009 EIP is 239,367,655 shares; provided, however, that only 67,500,000 shares may be issued or transferred pursuant to new awards granted on or following the effective date of the 2009 EIP. We may grant awards to employees, directors and other service providers. In the case of an incentive stock option granted to an employee who, at the time of the grant, owns stock representing more than 10% of the voting power of all classes of stock, the exercise price shall be no less than 110% of the fair market value per share on the date of grant and expire no more than five years from the date of grant, and options granted to any other employee, the per share exercise price shall be no less than 100% of the closing stock price on the date of grant. In the case of a non-statutory stock option and options granted to other service providers, the per share exercise price shall be no less than 100% of the fair market value per share on the date of grant. Options granted to individuals owning less than 10% of the total combined voting power of all classes of stock generally have a contractual term of no more than ten years and options generally vest over four years.

As of December 31, 2025, there were a total of 48.1 million shares of common stock available for grant under the 2009 EIP.
Restricted Stock Units

The following table summarizes the activity and related information for RSUs for the periods presented below (in millions, except per share amounts):
 Restricted Stock Units Outstanding
 Number of SharesWeighted-Average Grant Date Fair Value per Share
Balance—December 31, 2022
10.5 $40.94 
Granted4.8 60.14 
Forfeited(0.8)49.85 
Vested(5.4)35.47 
Balance—December 31, 2023
9.1 53.61 
Granted4.7 71.25 
Forfeited(1.0)61.98 
Vested(4.4)49.50 
Balance—December 31, 2024
8.4 64.70 
Granted3.8 97.88 
Forfeited(0.8)76.00 
Vested(3.8)62.01 
Balance—December 31, 2025
7.6 $81.51 

Stock compensation expense is recognized on a straight-line basis over the vesting period of each RSU. As of December 31, 2025, total compensation expense related to unvested RSUs granted to employees and non-employees under the 2009 EIP, but not yet recognized, was $537.2 million, with a weighted-average remaining vesting period of 2.7 years.

Market/Performance-Based PSUs

We grant market/performance-based PSUs under the 2009 EIP to certain of our executives. Based on the achievement of the market/performance-based vesting conditions during the performance period, the final settlement of the PSUs will range between 0% and 200% of the target shares underlying the PSUs based on the percentile ranking of our total stockholder return over one-, two-, three- and four-year periods among companies included in the S&P 500 Index. 20%, 20%, 20% and 40% of the PSUs vest over one-, two-, three- and four-year service periods, respectively.

The following table summarizes the weighted-average assumptions relating to our PSUs:
 Year Ended December 31,
 202520242023
Expected term in years2.72.72.7
Volatility41.7 %45.4 %47.5 %
Risk-free interest rate4.1 %4.5 %4.6 %
Dividend rate— %— %— %
The following table summarizes the activity and related information for PSUs for the periods presented below (in millions, except per share amounts):
 
Performance Stock Units Outstanding
 Number of SharesWeighted-Average Grant Date Fair Value per Share
Balance—December 31, 2022
— $— 
Granted0.3 90.96 
Forfeited— — 
Vested— — 
Balance—December 31, 2023
0.3 90.96 
Granted0.3 97.40 
Forfeited(0.1)93.84 
Vested(0.1)88.10 
Balance—December 31, 2024
0.4 94.93 
Granted0.2 163.23 
Forfeited(0.1)116.82 
Vested(0.1)91.19 
Balance—December 31, 2025
0.4 $117.17 

As of December 31, 2025, total compensation expense related to unvested PSUs that were granted to certain of our executives, but not yet recognized, was $21.2 million. This expense is expected to be amortized on a graded vesting method over a weighted-average vesting period of 2.1 years.

RSUs and PSUs settle into shares of common stock upon vesting. Upon the vesting of the RSUs and PSUs, we net-settle the RSUs and PSUs and withhold a portion of the shares to satisfy employee withholding tax requirements. The payment of the withheld taxes to the tax authorities is reflected as a financing activity within the consolidated statements of cash flows.

The following summarizes the number and value of the shares withheld for employee taxes (in millions):
Year Ended December 31,
202520242023
Shares withheld for taxes1.3 1.5 1.8 
Amount withheld for taxes$126.5 $101.0 $112.5 

Stock Options

In determining the fair value of our stock options, we use the Black-Scholes model, which employs the following assumptions.

Expected Term—The expected term represents the period that our stock-based awards are expected to be outstanding. We believe that we have sufficient historical experience for determining the expected term of the stock option award, and therefore, we calculated our expected term based on historical experience instead of using the simplified method.

Expected Volatility—The expected volatility of our common stock is based on our weighted-average implied and historical volatility.

Fair Value of Common Stock—The fair value of our common stock is the closing sales price of the common stock effective on the date of grant.

Risk-Free Interest Rate—We base the risk-free interest rate on the implied yield available on U.S. Treasury zero-coupon issues with an equivalent remaining term.
Expected Dividend—The expected dividend weighted-average assumption is zero.

The following table summarizes the weighted-average assumptions relating to our stock options:
 Year Ended December 31,
 202520242023
Expected term in years4.54.54.4
Volatility41.8 %42.6 %42.0 %
Risk-free interest rate4.1 %4.3 %4.2 %
Dividend rate— %— %— %

The following table summarizes the stock option activity and related information for the periods presented below (in millions, except exercise prices and contractual life):
 Options Outstanding
 Number
of Shares
Weighted-
Average
Exercise
Price
Weighted-
Average
Remaining
Contractual
Life (Years)
Aggregate
Intrinsic
Value
Balance—December 31, 2022
13.2 $24.37 3.5344.8 
Granted1.3 60.16 
Forfeited(0.2)49.13 
Exercised(3.1)14.11 
Balance—December 31, 2023
11.2 31.14 3.3315.8 
Granted0.8 68.21 
Forfeited(0.2)54.74 
Exercised(3.1)20.30 
Balance—December 31, 2024
8.7 37.81 3.1493.8 
Granted0.9 100.08 
Forfeited(0.1)74.07 
Exercised(2.1)21.59 
Balance—December 31, 2025
7.4 $49.39 
Options vested and expected to vest—December 31, 2025
7.4 $49.39 3.0$241.7 
Options exercisable—December 31, 2025
5.7 $39.53 2.3$228.6 

The aggregate intrinsic value represents the difference between the exercise price of stock options and the quoted market price of our common stock at the date of the balance sheet for all in-the-money stock options. Stock compensation expense is recognized on a straight-line basis over the vesting period of each stock option. As of December 31, 2025, total compensation expense related to unvested stock options granted to employees but not yet recognized was $50.6 million, with a weighted-average remaining vesting period of 2.6 years.

Additional information related to our stock options is summarized below (in millions, except per share amounts):
Year Ended December 31,
202520242023
Weighted-average fair value per share granted $40.21 $27.87 $24.20 
Intrinsic value of options exercised $166.3 $166.9 $140.7 
Fair value of options vested$26.8 $31.3 $30.1 
The following table summarizes information about outstanding and exercisable stock options as of December 31, 2025, (in millions, except exercise prices and contractual life):
 
 Options OutstandingOptions Exercisable
Range of Exercise Prices Number
Outstanding
Weighted-
Average
Remaining
Contractual
Life (Years)
Weighted-
Average
Exercise
Price
Number
Exercisable
Weighted-
Average
Exercise
Price
$16.02-$29.12
2.1 0.9$21.26 2.1 $21.26 
$34.39-$60.21
2.6 3.045.12 2.3 42.97 
$61.13-$79.61
1.8 4.064.61 1.3 63.21 
$79.73-$110.02
0.9 6.3101.44 — 100.88 
7.4 5.7 

Shares Reserved for Future Issuances

The following table presents the common stock reserved for future issuance (in millions):
December 31,
2025
Reserved for future equity award grants48.1 
Outstanding stock options, RSUs and PSUs
15.4 
Total common stock reserved for future issuances63.5 

Stock-Based Compensation Expense

Stock-based compensation expense, including stock-based compensation expense related to awards classified as liabilities, is included in costs and expenses (in millions):
 Year Ended December 31,
 202520242023
Cost of product revenue$2.2 $1.9 $1.8 
Cost of service revenue27.1 25.4 23.3 
Research and development98.7 85.9 76.8 
Sales and marketing117.2 105.3 111.8 
General and administrative36.9 41.7 37.9 
Total stock-based compensation expense$282.1 $260.2 $251.6 

The following table summarizes stock-based compensation expense, including stock-based compensation expense related to awards classified as liabilities, by award type (in millions):
 Year Ended December 31,
 202520242023
RSUs$239.8 $217.2 $211.8 
Stock options26.9 28.2 28.8 
PSUs
15.4 14.8 11.0 
Total stock-based compensation expense$282.1 $260.2 $251.6 
Total income tax benefit associated with stock-based compensation that is recognized in the consolidated statements of income is (in millions):
Year Ended December 31,
202520242023
Income tax benefit associated with stock-based compensation $61.7 $57.3 $55.5 

Share Repurchase Program

In January 2016, our board of directors approved the Repurchase Program, which authorized the repurchase of up to $200.0 million of our outstanding common stock through December 31, 2017. From 2016 through 2024, our board of directors approved increases to our Repurchase Program by various amounts and extended the term of the Repurchase Program to February 28, 2026. In August 2025, our board of directors approved a $1.0 billion increase in the authorized stock repurchase amount under the Repurchase Program and extended the term of the Repurchase Program to February 28, 2027, bringing the aggregate amount authorized for repurchases to $9.25 billion of our outstanding common stock through February 28, 2027. Under the Repurchase Program, we may repurchase common stock from time to time in privately negotiated transactions or in open market transactions. The Repurchase Program does not require us to purchase a minimum number of shares, and may be suspended, modified or discontinued at any time without prior notice. Refer to Note 16, Subsequent Events, for information regarding the approved $1.0 billion increase in the authorized stock repurchase amount under the Repurchase Program in January 2026.
In 2025, we repurchased 28.7 million shares of common stock under the Repurchase Program in open market transactions for an aggregate purchase price of $2.29 billion, which excludes an $18.3 million accrual related to the 1% excise tax imposed by the Inflation Reduction Act of 2022. As of December 31, 2025, $738.6 million remained available for future share repurchases under the Repurchase Program.
Free Sentinel

Want the next Fortinet, Inc. stock compensation disclosure the moment it drops?

Set a Sentinel and we'll alert you the moment Fortinet, Inc.'s next filing hits EDGAR. No credit card, your email never gets sold.

Track for free

Historical Timeline

Fiscal YearFiled
2025Feb 25, 2026Showing above
2024Feb 21, 2025
2023Feb 26, 2024
2022Feb 24, 2023
2021Feb 25, 2022

About Stock Compensation Disclosures

Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.

Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.